SEC Form 4 · accession 0001209191-15-026796
Adamas Pharmaceuticals Inc · ADMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Mar 13, 2015
Accepted (ET)
Mar 17, 2015 · 10:10 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2015 | S | 350,000 | $17.23 | D | 1,662,128 | D |
Table II — derivative securities
No Table II lines on this filing.